178 related articles for article (PubMed ID: 20676068)
1. k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.
Parry RM; Jones W; Stokes TH; Phan JH; Moffitt RA; Fang H; Shi L; Oberthuer A; Fischer M; Tong W; Wang MD
Pharmacogenomics J; 2010 Aug; 10(4):292-309. PubMed ID: 20676068
[TBL] [Abstract][Full Text] [Related]
2. Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.
Liu Q; Sung AH; Chen Z; Liu J; Huang X; Deng Y
PLoS One; 2009 Dec; 4(12):e8250. PubMed ID: 20011240
[TBL] [Abstract][Full Text] [Related]
3. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Shi L; Campbell G; Jones WD; Campagne F; Wen Z; Walker SJ; Su Z; Chu TM; Goodsaid FM; Pusztai L; Shaughnessy JD; Oberthuer A; Thomas RS; Paules RS; Fielden M; Barlogie B; Chen W; Du P; Fischer M; Furlanello C; Gallas BD; Ge X; Megherbi DB; Symmans WF; Wang MD; Zhang J; Bitter H; Brors B; Bushel PR; Bylesjo M; Chen M; Cheng J; Cheng J; Chou J; Davison TS; Delorenzi M; Deng Y; Devanarayan V; Dix DJ; Dopazo J; Dorff KC; Elloumi F; Fan J; Fan S; Fan X; Fang H; Gonzaludo N; Hess KR; Hong H; Huan J; Irizarry RA; Judson R; Juraeva D; Lababidi S; Lambert CG; Li L; Li Y; Li Z; Lin SM; Liu G; Lobenhofer EK; Luo J; Luo W; McCall MN; Nikolsky Y; Pennello GA; Perkins RG; Philip R; Popovici V; Price ND; Qian F; Scherer A; Shi T; Shi W; Sung J; Thierry-Mieg D; Thierry-Mieg J; Thodima V; Trygg J; Vishnuvajjala L; Wang SJ; Wu J; Wu Y; Xie Q; Yousef WA; Zhang L; Zhang X; Zhong S; Zhou Y; Zhu S; Arasappan D; Bao W; Lucas AB; Berthold F; Brennan RJ; Buness A; Catalano JG; Chang C; Chen R; Cheng Y; Cui J; Czika W; Demichelis F; Deng X; Dosymbekov D; Eils R; Feng Y; Fostel J; Fulmer-Smentek S; Fuscoe JC; Gatto L; Ge W; Goldstein DR; Guo L; Halbert DN; Han J; Harris SC; Hatzis C; Herman D; Huang J; Jensen RV; Jiang R; Johnson CD; Jurman G; Kahlert Y; Khuder SA; Kohl M; Li J; Li L; Li M; Li QZ; Li S; Li Z; Liu J; Liu Y; Liu Z; Meng L; Madera M; Martinez-Murillo F; Medina I; Meehan J; Miclaus K; Moffitt RA; Montaner D; Mukherjee P; Mulligan GJ; Neville P; Nikolskaya T; Ning B; Page GP; Parker J; Parry RM; Peng X; Peterson RL; Phan JH; Quanz B; Ren Y; Riccadonna S; Roter AH; Samuelson FW; Schumacher MM; Shambaugh JD; Shi Q; Shippy R; Si S; Smalter A; Sotiriou C; Soukup M; Staedtler F; Steiner G; Stokes TH; Sun Q; Tan PY; Tang R; Tezak Z; Thorn B; Tsyganova M; Turpaz Y; Vega SC; Visintainer R; von Frese J; Wang C; Wang E; Wang J; Wang W; Westermann F; Willey JC; Woods M; Wu S; Xiao N; Xu J; Xu L; Yang L; Zeng X; Zhang J; Zhang L; Zhang M; Zhao C; Puri RK; Scherf U; Tong W; Wolfinger RD;
Nat Biotechnol; 2010 Aug; 28(8):827-38. PubMed ID: 20676074
[TBL] [Abstract][Full Text] [Related]
4. Selecting a single model or combining multiple models for microarray-based classifier development?--a comparative analysis based on large and diverse datasets generated from the MAQC-II project.
Chen M; Shi L; Kelly R; Perkins R; Fang H; Tong W
BMC Bioinformatics; 2011 Oct; 12 Suppl 10(Suppl 10):S3. PubMed ID: 22166133
[TBL] [Abstract][Full Text] [Related]
5. Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients.
Oberthuer A; Juraeva D; Li L; Kahlert Y; Westermann F; Eils R; Berthold F; Shi L; Wolfinger RD; Fischer M; Brors B
Pharmacogenomics J; 2010 Aug; 10(4):258-66. PubMed ID: 20676065
[TBL] [Abstract][Full Text] [Related]
6. A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data.
Luo J; Schumacher M; Scherer A; Sanoudou D; Megherbi D; Davison T; Shi T; Tong W; Shi L; Hong H; Zhao C; Elloumi F; Shi W; Thomas R; Lin S; Tillinghast G; Liu G; Zhou Y; Herman D; Li Y; Deng Y; Fang H; Bushel P; Woods M; Zhang J
Pharmacogenomics J; 2010 Aug; 10(4):278-91. PubMed ID: 20676067
[TBL] [Abstract][Full Text] [Related]
7. Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Zhang W; Yu Y; Hertwig F; Thierry-Mieg J; Zhang W; Thierry-Mieg D; Wang J; Furlanello C; Devanarayan V; Cheng J; Deng Y; Hero B; Hong H; Jia M; Li L; Lin SM; Nikolsky Y; Oberthuer A; Qing T; Su Z; Volland R; Wang C; Wang MD; Ai J; Albanese D; Asgharzadeh S; Avigad S; Bao W; Bessarabova M; Brilliant MH; Brors B; Chierici M; Chu TM; Zhang J; Grundy RG; He MM; Hebbring S; Kaufman HL; Lababidi S; Lancashire LJ; Li Y; Lu XX; Luo H; Ma X; Ning B; Noguera R; Peifer M; Phan JH; Roels F; Rosswog C; Shao S; Shen J; Theissen J; Tonini GP; Vandesompele J; Wu PY; Xiao W; Xu J; Xu W; Xuan J; Yang Y; Ye Z; Dong Z; Zhang KK; Yin Y; Zhao C; Zheng Y; Wolfinger RD; Shi T; Malkas LH; Berthold F; Wang J; Tong W; Shi L; Peng Z; Fischer M
Genome Biol; 2015 Jun; 16(1):133. PubMed ID: 26109056
[TBL] [Abstract][Full Text] [Related]
8. Gene expression cancer classification using modified K-Nearest Neighbors technique.
Ayyad SM; Saleh AI; Labib LM
Biosystems; 2019 Feb; 176():41-51. PubMed ID: 30611843
[TBL] [Abstract][Full Text] [Related]
9. Clustering of significant genes in prognostic studies with microarrays: application to a clinical study for multiple myeloma.
Matsui S; Yamanaka T; Barlogie B; Shaughnessy JD; Crowley J
Stat Med; 2008 Mar; 27(7):1106-20. PubMed ID: 17680552
[TBL] [Abstract][Full Text] [Related]
10. EKNN: Ensemble classifier incorporating connectivity and density into kNN with application to cancer diagnosis.
Mahfouz MA; Shoukry A; Ismail MA
Artif Intell Med; 2021 Jan; 111():101985. PubMed ID: 33461685
[TBL] [Abstract][Full Text] [Related]
11. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.
Schramm A; Schulte JH; Klein-Hitpass L; Havers W; Sieverts H; Berwanger B; Christiansen H; Warnat P; Brors B; Eils J; Eils R; Eggert A
Oncogene; 2005 Nov; 24(53):7902-12. PubMed ID: 16103881
[TBL] [Abstract][Full Text] [Related]
12. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
[TBL] [Abstract][Full Text] [Related]
13. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
14. Microarrays in the clinic.
Tillinghast GW
Nat Biotechnol; 2010 Aug; 28(8):810-2. PubMed ID: 20697405
[No Abstract] [Full Text] [Related]
15. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.
Ohira M; Oba S; Nakamura Y; Isogai E; Kaneko S; Nakagawa A; Hirata T; Kubo H; Goto T; Yamada S; Yoshida Y; Fuchioka M; Ishii S; Nakagawara A
Cancer Cell; 2005 Apr; 7(4):337-50. PubMed ID: 15837623
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
Anguiano A; Tuchman SA; Acharya C; Salter K; Gasparetto C; Zhan F; Dhodapkar M; Nevins J; Barlogie B; Shaughnessy JD; Potti A
J Clin Oncol; 2009 Sep; 27(25):4197-203. PubMed ID: 19636021
[TBL] [Abstract][Full Text] [Related]
17. Introduction to machine learning: k-nearest neighbors.
Zhang Z
Ann Transl Med; 2016 Jun; 4(11):218. PubMed ID: 27386492
[TBL] [Abstract][Full Text] [Related]
18. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
[TBL] [Abstract][Full Text] [Related]
19. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
[TBL] [Abstract][Full Text] [Related]
20. Robust Distance Measures for
Ehsani R; Drabløs F
Cancer Inform; 2020; 19():1176935120965542. PubMed ID: 33116353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
